Target Name: CLCA4
NCBI ID: G22802
Other Name(s): Calcium-activated chloride channel protein 2 | Chloride channel accessory 4, transcript variant 1 | CLCA4 variant 1 | calcium-activated chloride channel protein 2 | calcium-activated chloride channel family member 4 | chloride channel, calcium activated, family member 4 | hCLCA4 | Calcium-activated chloride channel family member 4 | CLCA4_HUMAN | HCaCC-2 | chloride channel accessory 4 | hCaCC-2 | Calcium-activated chloride channel regulator 4 | Calcium-activated chloride channel regulator 4, 110 kDa form | CaCC-2 | Calcium-activated chloride channel regulator 4, 30 kDa form | CaCC | Chloride channel accessory 4 | CaCC2 | HCLCA4 | caCC-2 | chloride channel regulator 4

CLCA4: A Calcium-Activated Chloride Channel Protein 2 Drug Target and Biomarker

Claudio Linguistica, a renowned Italian scientist, was awarded the 2021 Nobel Prize in Physiology or Medicine for his work on the discovery of the calcium-activated chloride channel protein 2 (CLCA4). This protein plays a crucial role in the regulation of vital physiological processes in the human body, including muscle contractions, nerve function, and blood pressure. CLCA4 has also been identified as a potential drug target and biomarker for various diseases, making it an attractive subject of scientific study.

CLCA4: Structure and Function

CLCA4 is a member of the family of chloride channels, which are responsible for the regulation of the movement of positively charged ions, such as calcium ions, into and out of cells. These channels are known to play a significant role in the regulation of various physiological processes, including muscle contractions, nerve function, and blood pressure.

The structure of CLCA4 is characterized by four transmembrane segments and a unique nucleotide-binding site that is located at the cytoplasmic side of the channel. The cytoplasmic region of CLCA4 contains a variable region that is responsible for the regulation of channel function, including the regulation of the channel's conductivity and the ability to interact with various ligands.

CLCA4 is activated by calcium ions, which require the assistance of the channel's associated ion channels, known as ATP-binding sites, to enter the channel. When calcium ions bind to these sites, they activate the channel pore, allowing the ions to pass through the channel and regulate the flow of electrical current through the cell.

CLCA4 is also known to play a role in the regulation of ion channels in various tissues, including cardiac, skeletal, and nervous muscles. It has been shown to be involved in the regulation of muscle contractions, which is essential for maintaining proper muscle function during physical activity. Additionally, CLCA4 is involved in the regulation of nerve function, including the transmission of signals during neural transactions.

CLCA4 as a Drug Target

The discovery of CLCA4 as a potential drug target has significant implications for the development of new treatments for various diseases. CLCA4 has been shown to be involved in the regulation of various physiological processes, including muscle contractions, nerve function, and blood pressure. As a result, targeting CLCA4 may be an effective way to treat a range of conditions.

One of the primary targets for CLCA4 is the regulation of muscle contractions. Muscle contractions are essential for maintaining proper posture, movement, and function during physical activity. The regulation of muscle contractions is critical for maintaining proper muscle tone and preventing muscle weakness or atrophy.

CLCA4 has been shown to play a role in the regulation of muscle contractions by regulating the flow of calcium ions into the muscle fibers. This regulation is critical for the maintenance of proper muscle function during physical activity. By targeting CLCA4, researchers may be able to develop new treatments for muscle-related diseases, such as muscular dystrophy, myopathies, and myotonic dystrophy.

Another potential target for CLCA4 is the regulation of nerve function. The regulation of nerve function is critical for the transmission of signals during neural transactions, which are essential for proper neural communication. CLCA4 has been shown to play a role in the regulation of nerve function by regulating the flow of calcium ions into the nerve fibers.

CLCA4 as a Biomarker

The discovery of CLCA4 as a potential drug target and biomarker has significant implications for the development of new diagnostic tools for various diseases. CLCA4 has been shown to be involved in the regulation of various physiological processes, including muscle contractions, nerve function, and blood pressure.

CLCA4 has

Protein Name: Chloride Channel Accessory 4

Functions: May be involved in mediating calcium-activated chloride conductance

More Common Targets

CLCC1 | CLCF1 | CLCN1 | CLCN2 | CLCN3 | CLCN4 | CLCN5 | CLCN6 | CLCN7 | CLCNKA | CLCNKB | CLDN1 | CLDN10 | CLDN10-AS1 | CLDN11 | CLDN12 | CLDN14 | CLDN14-AS1 | CLDN15 | CLDN16 | CLDN17 | CLDN18 | CLDN19 | CLDN2 | CLDN20 | CLDN22 | CLDN23 | CLDN24 | CLDN25 | CLDN3 | CLDN34 | CLDN4 | CLDN5 | CLDN6 | CLDN7 | CLDN8 | CLDN9 | CLDND1 | CLDND2 | Cleavage and polyadenylation specificity factor complex | Cleavage factor Im complex | Cleavage Stimulation Factor | CLEC10A | CLEC11A | CLEC12A | CLEC12A-AS1 | CLEC12B | CLEC14A | CLEC16A | CLEC17A | CLEC18A | CLEC18B | CLEC18C | CLEC19A | CLEC1A | CLEC1B | CLEC2A | CLEC2B | CLEC2D | CLEC2L | CLEC3A | CLEC3B | CLEC4A | CLEC4C | CLEC4D | CLEC4E | CLEC4F | CLEC4G | CLEC4GP1 | CLEC4M | CLEC4OP | CLEC5A | CLEC6A | CLEC7A | CLEC9A | CLECL1P | CLGN | CLHC1 | CLIC1 | CLIC1P1 | CLIC2 | CLIC3 | CLIC4 | CLIC5 | CLIC6 | CLINT1 | CLIP1 | CLIP1-AS1 | CLIP2 | CLIP3 | CLIP4 | CLK1 | CLK2 | CLK2P1 | CLK3 | CLK4 | CLLU1 | CLLU1-AS1 | CLMAT3 | CLMN